These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 8319174)
1. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Westra WH; Slebos RJ; Offerhaus GJ; Goodman SN; Evers SG; Kensler TW; Askin FB; Rodenhuis S; Hruban RH Cancer; 1993 Jul; 72(2):432-8. PubMed ID: 8319174 [TBL] [Abstract][Full Text] [Related]
2. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. Slebos RJ; Hruban RH; Dalesio O; Mooi WJ; Offerhaus GJ; Rodenhuis S J Natl Cancer Inst; 1991 Jul; 83(14):1024-7. PubMed ID: 2072410 [TBL] [Abstract][Full Text] [Related]
3. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression. Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804 [TBL] [Abstract][Full Text] [Related]
5. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Westra WH; Offerhaus GJ; Goodman SN; Slebos RJ; Polak M; Baas IO; Rodenhuis S; Hruban RH Am J Surg Pathol; 1993 Mar; 17(3):213-20. PubMed ID: 8434702 [TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes. Porta M; Crous-Bou M; Wark PA; Vineis P; Real FX; Malats N; Kampman E Mutat Res; 2009; 682(2-3):83-93. PubMed ID: 19651236 [TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase mu1 null genotype is associated with K-ras gene mutation in lung adenocarcinoma among smokers. Matsuzoe D; Hideshima T; Iwasaki A; Yoneda S; Kawahara K; Shirakusa T; Kimura A Carcinogenesis; 2001 Aug; 22(8):1327-30. PubMed ID: 11470766 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners. Sarkar FH; Li Y; Vallyathan V Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787 [TBL] [Abstract][Full Text] [Related]
10. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Rodenhuis S; Slebos RJ; Boot AJ; Evers SG; Mooi WJ; Wagenaar SS; van Bodegom PC; Bos JL Cancer Res; 1988 Oct; 48(20):5738-41. PubMed ID: 3048648 [TBL] [Abstract][Full Text] [Related]
11. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
12. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876 [TBL] [Abstract][Full Text] [Related]
13. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. Slebos RJ; Kibbelaar RE; Dalesio O; Kooistra A; Stam J; Meijer CJ; Wagenaar SS; Vanderschueren RG; van Zandwijk N; Mooi WJ N Engl J Med; 1990 Aug; 323(9):561-5. PubMed ID: 2199829 [TBL] [Abstract][Full Text] [Related]
14. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas. Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543 [TBL] [Abstract][Full Text] [Related]
15. Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Lung ML; Wong M; Lam WK; Lau KS; Kwan S; Fu KH; Cheung H; Yew WW Cancer; 1992 Aug; 70(4):760-3. PubMed ID: 1322782 [TBL] [Abstract][Full Text] [Related]
16. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers. Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700 [TBL] [Abstract][Full Text] [Related]
17. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status. Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699 [TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Soung YH; Lee JW; Kim SY; Seo SH; Park WS; Nam SW; Song SY; Han JH; Park CK; Lee JY; Yoo NJ; Lee SH Virchows Arch; 2005 May; 446(5):483-8. PubMed ID: 15815931 [TBL] [Abstract][Full Text] [Related]
19. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis. Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799 [TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Ahrendt SA; Decker PA; Alawi EA; Zhu Yr YR; Sanchez-Cespedes M; Yang SC; Haasler GB; Kajdacsy-Balla A; Demeure MJ; Sidransky D Cancer; 2001 Sep; 92(6):1525-30. PubMed ID: 11745231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]